News
Hopeful candidate
The novel anticoagulant Xarelto® (rivaroxaban) can already be used for the prevention of venous thromboembolism in adults following elective hip or knee replacement surgery in more than 20 countries, including the countries in the European Union, China, Canada, Mexico, Australia and Singapore. » more
UN Environment Programme
Young Environmental Envoys visit Bayer
At the beginning of November 2008, 50 Young Environmental Envoys from 18 countries on four continents spent a week in Leverkusen, Germany, to fi nd out about developments in and prospects for environmental protection and sustainable development. » more
Innovative collaboration
Cooperation in the battle against cancer
In November 2008, the German Cancer Research Center and Bayer HealthCare formed a strategic research alliance scheduled to run for an initial period of two years. » more
Carbon Nanotubes
New pilot plant for carbon nanotubes
Bayer MaterialScience started work on the construction of a new pilot facility for carbon nanotubes (CNTS) in January 2009. The new plant in Leverkusen will have a capacity of 200 metric tons per year, making it one of the largest of its kind in the world. » more
2:40 min.

Enter the relevant code given in the printed version of the Sustainable Development Report